Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia
Authors
Keywords
-
Journal
IMMUNOLOGY
Volume 139, Issue 4, Pages 513-522
Publisher
Wiley
Online
2013-03-24
DOI
10.1111/imm.12101
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Prevalence Of Cervical Regulatory T Cells in HPV-Related Cervical Intraepithelial Neoplasia (CIN) Correlates Inversely with Spontaneous Regression of CIN
- (2012) Satoko Kojima et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Characterization of Gut-Derived Intraepithelial Lymphocyte (IEL) Residing in Human Papillomavirus (HPV)-Infected Intraepithelial Neoplastic Lesions
- (2011) Satoko Kojima et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Incident Cervical HPV Infections in Young Women: Transition Probabilities for CIN and Infection Clearance
- (2011) R. P. Insinga et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The PD-1/PD-L1 (B7-H1) Pathway in Chronic Infection-Induced Cytotoxic T Lymphocyte Exhaustion
- (2011) Kimberly A. Hofmeyer et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Enhancement of Vaccine-induced Primary and Memory CD8+ T-cell Responses by Soluble PD-1
- (2011) Mi-Young Song et al. JOURNAL OF IMMUNOTHERAPY
- Molecular Mechanism and Potential Targets for Blocking HPV-Induced Lesion Development
- (2011) E. Guzmán-Olea et al. Journal of Oncology
- Up-Regulation of 14-3-3σ (Stratifin) Is Associated With High-Grade CIN and High-Risk Human Papillomavirus (HPV) at Baseline but Does Not Predict Outcomes of HR-HPV Infections or Incident CIN in the LAMS Study
- (2010) Stina Syrjänen et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- PD-L1 expression on tolerogenic APCs is controlled by STAT-3
- (2010) Sabine J. Wölfle et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Human Papillomavirus 16-Associated Cervical Intraepithelial Neoplasia in Humans Excludes CD8 T Cells from Dysplastic Epithelium
- (2010) C. L. Trimble et al. JOURNAL OF IMMUNOLOGY
- PD-1 on Immature and PD-1 Ligands on Migratory Human Langerhans Cells Regulate Antigen-Presenting Cell Activity
- (2010) Victor Peña-Cruz et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Increased PD-L1 expression and PD-L1/CD86 ratio on dendritic cells were associated with impaired dendritic cells function in HCV infection
- (2010) Tao Shen et al. JOURNAL OF MEDICAL VIROLOGY
- Programmed death-1–induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection
- (2010) Elias A Said et al. NATURE MEDICINE
- Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells
- (2009) Xian-Zhen Chen et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
- (2009) Loise M. Francisco et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients
- (2009) Zheng Zhang et al. JOURNAL OF HEPATOLOGY
- Correlation Between IL-10 Gene Expression and HPV Infection in Cervical Cancer: A Mechanism for Immune Response Escape
- (2008) Victor H. Bermúdez-Morales et al. CANCER INVESTIGATION
- Diminished IFN-γ and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3
- (2008) Mark E. Scott et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started